The health secretary says he will balance the arguments for and against mass testing ahead of a final decision due in March.

The recent FDA approval of the IsoPSA blood test may represent a notable advancement in prostate cancer screening and diagnosis. Developed by Cleveland Diagnostics, the in vitro diagnostic instrument ...

The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for ...

A marathon runner has said a prostate cancer test would have saved him from his terminal diagnosis. Tony Collier, 68, who has ...

Mass population testing for prostate cancer will not see men proactively invited for the PSA blood test - here is all you ...

The FDA approved Cleveland Diagnostics' blood-based test to help diagnose high-grade prostate tumors and aid in biopsy decisions, the company announced.

IT affects one in eight men, and so it seems logical to have a prostate cancer screening programme. And yet, in a pivotal ...

IsoPSA Test Evaluates Prostate Cancer-Specific Structural Variants of the PSA Protein to Aid in the Diagnosis of High-Grade Prostate Cancer ...

A large primary care analysis shows prostate cancer screening remains underused and inequitable, with notable gaps for African American and low-income high-risk patients despite multiple risk factors.

Editor's note: Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and an assistant professor at the University of Central Florida’s College of Medicine.When I learned that ...

A roster of high profile advocates, including sportsmen, actors, two previous prime ministers and over 100 MPs, have recently ...

The NHS does not offer routine prostate cancer screening for all men. The PSA (prostate-specific antigen) test, which ...